NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot form of cancer drug shows promise in early testing
Disease control CompletedThis study looked at giving nivolumab as a shot under the skin instead of through an IV. It included 139 people with advanced cancers like lung, kidney, melanoma, liver, and colorectal cancer. The main goal was to measure how much drug gets into the blood and how long it stays. R…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 01, 2026 15:29 UTC
-
Experimental cell therapy targets tough blood cancers
Disease control CompletedThis early-stage study tested a new treatment called RD13-02, a type of CAR-T cell therapy, in 2 patients with blood cancers (like leukemia or lymphoma) that had come back or stopped responding to standard treatments. The main goal was to see if the treatment was safe and to lear…
Matched conditions: NEOPLASMS BY SITE
Phase: EARLY_PHASE1 • Sponsor: MEI HENG • Aim: Disease control
Last updated Apr 29, 2026 15:13 UTC
-
New combo therapy shows promise in Hard-to-Treat cancers
Disease control CompletedThis study tested an experimental drug (BMS-986016) that targets a protein called LAG-3 on immune cells, given alone or with the immunotherapy nivolumab. It included nearly 1,500 adults with advanced solid tumors like lung, stomach, liver, kidney, bladder, head and neck, and skin…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New scan spots cancers standard MRI misses in prostate patients
Diagnosis CompletedThis study tested whether advanced PET-MRI scans can find prostate cancers that standard MRI might miss. 62 men who were considering focal therapy or prostate removal took part. The goal was to see if the new imaging could better map cancer locations and severity, helping doctors…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE2 • Sponsor: Alessandro D'Agnolo • Aim: Diagnosis
Last updated Apr 30, 2026 15:50 UTC